ResearcherWuhan Union HospitalActive in the last 2 years

Yizhou Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7141-9509; OpenAlex author ID A5100679214. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2026: 1 paper

Papers 1

PRMT1-Mediated Arginine Methylation Redirects SMAD4 Signaling to Promote Metastasis in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-26-0923 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yingke Zhou · 1 shared paper, 2026 · strength 0.26
- Paper PRMT1-Mediated Arginine Methylation Redirects SMAD4 Signaling to Promote Metastasis in Pancreatic Cancer. DOI 10.1158/0008-5472.can-26-0923 ↗
Tao Yin · 1 shared paper, 2026 · strength 0.26
- Paper PRMT1-Mediated Arginine Methylation Redirects SMAD4 Signaling to Promote Metastasis in Pancreatic Cancer. DOI 10.1158/0008-5472.can-26-0923 ↗
Gengdu Qin · 1 shared paper, 2026 · strength 0.26
- Paper PRMT1-Mediated Arginine Methylation Redirects SMAD4 Signaling to Promote Metastasis in Pancreatic Cancer. DOI 10.1158/0008-5472.can-26-0923 ↗
Taoyu Chen · 1 shared paper, 2026 · strength 0.26
- Paper PRMT1-Mediated Arginine Methylation Redirects SMAD4 Signaling to Promote Metastasis in Pancreatic Cancer. DOI 10.1158/0008-5472.can-26-0923 ↗
Hongkun Cai · 1 shared paper, 2026 · strength 0.26
- Paper PRMT1-Mediated Arginine Methylation Redirects SMAD4 Signaling to Promote Metastasis in Pancreatic Cancer. DOI 10.1158/0008-5472.can-26-0923 ↗
Shanmiao Gou · 1 shared paper, 2026 · strength 0.26
- Paper PRMT1-Mediated Arginine Methylation Redirects SMAD4 Signaling to Promote Metastasis in Pancreatic Cancer. DOI 10.1158/0008-5472.can-26-0923 ↗
Heshui Wu · 1 shared paper, 2026 · strength 0.26
- Paper PRMT1-Mediated Arginine Methylation Redirects SMAD4 Signaling to Promote Metastasis in Pancreatic Cancer. DOI 10.1158/0008-5472.can-26-0923 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.